Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Director departure
Appointed director

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 6.3% stake in Iovance Biotherapeutics, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.2% stake in Iovance Biotherapeutics Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/24/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 6.5% stake in Iovance Biotherapeutics, Inc.
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 2.9% stake in IOVANCE BIOTHERAPEUTICS, INC.
02/11/2022 SC 13G/A Avoro Capital Advisors LLC reports a 5.5% stake in Iovance Biotherapeutics, Inc.
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 7.8% stake in Iovance Biotherapeutics Inc.
02/04/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 6.3% stake in Iovance Biotherapeutics, Inc.
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Avoro Capital Advisors LLC reports a 5.1% stake in Iovance Biotherapeutics, Inc.
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/24/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 7.5% stake in Iovance Biotherapeutics, Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/05/2020 SC 13G/A BlackRock Inc. reports a 7.6% stake in IOVANCE BIOTHERAPEUTICS INC
02/04/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A venBio Select Advisor LLC reports a 8.9% stake in Iovance Biotherapeutics, Inc.
02/13/2019 SC 13G/A Broadfin Capital, LLC reports a 4.8% stake in Iovance Biotherapeutics, Inc.
02/12/2019 SC 13G/A ORBIMED ADVISORS LLC reports a 3.4% stake in Iovance Biotherapeutics, Inc.
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/28/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 4.3% stake in Iovance Biotherapeutics, Inc.
02/13/2018 SC 13G/A ORBIMED ADVISORS LLC reports a 4.5% stake in Iovance Biotherapeutics, Inc.
02/13/2018 SC 13G/A FMR LLC reports a 2.5% stake in IOVANCE BIOTHERAPEUTICS INC
02/12/2018 SC 13G/A venBio Select Advisor LLC reports a 7.2% stake in Iovance Biotherapeutics, Inc.
02/07/2018 SC 13G/A FRANKLIN RESOURCES INC reports a 6.9% stake in IOVANCE BIOTHERAPEUTICS, INC.
08/02/2017 SC 13G/A ACUTA CAPITAL PARTNERS, LLC reports a 6.4% stake in IOVANCE BIOTHERAPEUTICS, INC.
05/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2017 SC 13G/A Lion Biotechnologies, Inc. reports a 6.1% stake in LION BIOTECHNOLOGIES, INC.
02/14/2017 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 5.7% stake in Lion Biotechnologies, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy